GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Bionik Laboratories Corp (OTCPK:BNKL) » Definitions » Cyclically Adjusted PB Ratio

Bionik Laboratories (Bionik Laboratories) Cyclically Adjusted PB Ratio : 0.00 (As of May. 04, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Bionik Laboratories Cyclically Adjusted PB Ratio?

As of today (2024-05-04), Bionik Laboratories's current share price is $0.10. Bionik Laboratories's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2023 was $24.05. Bionik Laboratories's Cyclically Adjusted PB Ratio for today is 0.00.

The historical rank and industry rank for Bionik Laboratories's Cyclically Adjusted PB Ratio or its related term are showing as below:

BNKL's Cyclically Adjusted PB Ratio is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.045
* Ranked among companies with meaningful Cyclically Adjusted PB Ratio only.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Bionik Laboratories's adjusted book value per share data for the three months ended in Mar. 2023 was $-0.239. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $24.05 for the trailing ten years ended in Mar. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bionik Laboratories Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Bionik Laboratories's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bionik Laboratories Cyclically Adjusted PB Ratio Chart

Bionik Laboratories Annual Data
Trend Dec14 Dec15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.11 0.02 0.02

Bionik Laboratories Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.04 0.01 0.03 0.02

Competitive Comparison of Bionik Laboratories's Cyclically Adjusted PB Ratio

For the Medical Care Facilities subindustry, Bionik Laboratories's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bionik Laboratories's Cyclically Adjusted PB Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Bionik Laboratories's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Bionik Laboratories's Cyclically Adjusted PB Ratio falls into.



Bionik Laboratories Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Bionik Laboratories's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.10/24.05
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bionik Laboratories's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2023 is calculated as:

For example, Bionik Laboratories's adjusted Book Value per Share data for the three months ended in Mar. 2023 was:

Adj_Book=Book Value per Share/CPI of Mar. 2023 (Change)*Current CPI (Mar. 2023)
=-0.239/127.3478*127.3478
=-0.239

Current CPI (Mar. 2023) = 127.3478.

Bionik Laboratories Quarterly Data

Book Value per Share CPI Adj_Book
201306 -0.008 98.518 -0.010
201309 -0.011 98.790 -0.014
201312 -0.016 98.326 -0.021
201403 -0.017 99.695 -0.022
201406 -0.022 100.560 -0.028
201409 -0.025 100.428 -0.032
201412 -0.571 99.070 -0.734
201503 55.720 99.621 71.228
201506 62.376 100.684 78.895
201509 54.746 100.392 69.446
201512 6.540 99.792 8.346
201603 1.753 100.470 2.222
201606 102.546 101.688 128.422
201609 80.744 101.861 100.947
201612 78.661 101.863 98.341
201703 74.101 102.862 91.740
201706 62.706 103.349 77.267
201709 58.102 104.136 71.053
201712 50.272 104.011 61.551
201803 14.948 105.290 18.080
201806 14.488 106.317 17.354
201809 11.507 106.507 13.759
201812 10.567 105.998 12.695
201903 7.485 107.251 8.888
201906 6.908 108.070 8.140
201909 6.433 108.329 7.562
201912 5.905 108.420 6.936
202003 2.659 108.902 3.109
202006 2.339 108.767 2.739
202009 2.057 109.815 2.385
202012 0.289 109.897 0.335
202103 0.587 111.754 0.669
202106 0.522 114.631 0.580
202109 0.404 115.734 0.445
202112 -0.767 117.630 -0.830
202203 0.433 121.301 0.455
202206 0.236 125.017 0.240
202209 0.077 125.227 0.078
202212 -0.077 125.222 -0.078
202303 -0.239 127.348 -0.239

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bionik Laboratories  (OTCPK:BNKL) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Bionik Laboratories Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Bionik Laboratories's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bionik Laboratories (Bionik Laboratories) Business Description

Traded in Other Exchanges
N/A
Address
80 Coolidge Hill Road, Watertown, MA, USA, 02472
Bionik Laboratories Corp is a healthcare company focused on improving the quality of life of millions of people with neurological or mobility impairments by combining artificial intelligence and innovative robotics technology to help individuals from hospital to home regain mobility, enhance autonomy, and regain self-esteem. The company uses artificial intelligence and machine learning technologies to make rehabilitation methods and processes smarter and more intuitive to deliver a greater recovery for patients with neurological or mobility impairments. Its products The InMotion ARM, and InMotion ARM/HAND are robotic therapies for the upper limbs.
Executives
Remi Gaston-dreyfus director, 10 percent owner 46 RUE PIERRE CHARRON, PARIS I0 75008
Charles Matine director 7 RUE GUSTAVE, FLAUBERT, PARIS I0 75017
Andre-jacques Auberton-herve director, officer: Chairman 18 CHEMIN DE LA VIERGE NOIRE, LA TRONCHE I0 38700
Daniel Gonsalves officer: Executive Vice President & CFO 80 COOLIDGE HILL ROAD, WATERTOWN MA 02472
Loren W. Wass officer: See Remarks 34 HOG HILL ROAD, PEPPERELL MA 01463
Joseph R Martin director
Audrey Thevenon director 4500 WESTBROOK LANE, KENSINGTON MD 20895
Peter Gerald Malone director
Russo Richard Paul Jr officer: Chief Financial Officer 20 PLUNKETT WAY, TEWKSBURY MA 01876
Renaud Bertrand Maloberti officer: Chief Commercial Officer 10 ACORN WAY, GEORGETOWN MA 01833
Timothy A. Mccarthy officer: Chief Commercialization Office C/O BIONIK, 483 BAY STREET, N105, TORONTO A6 M5G 2C9
Eric Michel Dusseux director 1 RUE DU CAPOT, CALUIRE-ET-CUIRE I0 69300
Jules Marc Fried officer: VP - U.S. Operations C/O INTERACTIVE MOTION TECHNOLOGIES INC., 80 COOLIDGE HILL ROAD, WATERTOWN MA 02472
Hermano Igo Krebs officer: Chief Science Officer C/O INTERACTIVE MOTION TECHNOLOGIES INC., 80 COOLIDGE HILL ROAD, WATERTOWN MA 02472
Marc Mathieu director 716 BROOKS AVENUE, VENICE CA 90291